Jpmorgan Chase & CO Rhythm Pharmaceuticals, Inc. Transaction History

Jpmorgan Chase & CO

$1.22 Trillion
Q3 2024

A detailed history of Jpmorgan Chase & CO transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 81,592 shares of RYTM stock, worth $4.58 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

81,592

Previous 140,146 41.78%

Holding current value

$4.58 Million

Previous $5.75 Million 25.72%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$40.81 - $55.0 $2.39 Million - $3.22 Million	-58,554 Reduced 41.78%	81,592 $4.27 Million
Q2 2024 Aug 12, 2024	BUY	$35.41 - $44.37 $3.03 Million - $3.8 Million	85,642 Added 157.13%	140,146 $5.75 Million
Q1 2024 May 10, 2024	SELL	$39.12 - $52.44 $903,476 - $1.21 Million	-23,095 Reduced 29.76%	54,504 $2.36 Million
Q4 2023 Feb 12, 2024	BUY	$21.39 - $49.64 $110,971 - $257,532	5,188 Added 7.16%	77,599 $3.57 Million
Q3 2023 Nov 14, 2023	BUY	$15.81 - $27.8 $44,631 - $78,479	2,823 Added 4.06%	72,411 $1.66 Million
Q2 2023 Aug 11, 2023	BUY	$16.32 - $21.15 $771,984 - $1 Million	47,303 Added 212.26%	69,588 $1.15 Million
Q1 2023 May 18, 2023	BUY	$16.88 - $34.24 $368,000 - $746,466	21,801 Added 4504.34%	22,285 $397,000
Q1 2023 May 11, 2023	SELL	$16.88 - $34.24 $323,370 - $655,935	-19,157 Reduced 97.54%	484 $8,000
Q4 2022 Feb 13, 2023	BUY	$22.21 - $30.25 $387,120 - $527,257	17,430 Added 788.33%	19,641 $572,000
Q3 2022 Nov 14, 2022	BUY	$4.3 - $30.85 $7,611 - $54,604	1,770 Added 401.36%	2,211 $54,000
Q2 2022 Aug 11, 2022	SELL	$3.12 - $12.25 $82,804 - $325,115	-26,540 Reduced 98.37%	441 $2,000
Q1 2022 May 11, 2022	BUY	$6.13 - $12.24 $28,817 - $57,540	4,701 Added 21.1%	26,981 $312,000
Q4 2021 Feb 10, 2022	SELL	$8.62 - $13.9 $1,905 - $3,071	-221 Reduced 0.98%	22,280 $223,000
Q3 2021 Nov 12, 2021	BUY	$11.68 - $20.72 $262,811 - $466,220	22,501 New	22,501 $293,000

Others Institutions Holding RYTM

# of Institutions

191

Shares Held

67.3M

Call Options Held

834K

Put Options Held

78.6K

View Full List

About RHYTHM PHARMACEUTICALS, INC.

Ticker RYTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,720,000
Market Cap $3.13B
Description
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...

More about RYTM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Rhythm Pharmaceuticals, Inc. Transaction History